Could possibly be Friday according to last PR, but I'm sure they will combine or divide news according to what they believe will have greatest impact.
Should be nice to get news on Milestones for NR2F6/NR2F2 breakthroughs with potential IND for even multi-combo drug trials and news on CRO and the beginning of safety trials for HemaX. If both happen in time for AACR or day following follow up PR, should be some positive action around here.
Market Data 
Markets 
AI
